Canine teratogenesis with an estrogen antagonist.
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000818:Animals; D000840:Anisoles / Q000009:adverse effects; D001724:Birth Weight; D002972:Cleft Palate / Q000139:chemically induced; D003270:Contraceptive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004285:Dogs / Q000196:embryology*; D004965:Estrogen Antagonists; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D006614:Hindlimb / Q000002:abnormalities; D011247:Pregnancy; D011759:Pyrrolidines / Q000009:adverse effects*; D013249:Sternum / Q000002:abnormalities; D013343:Styrenes / Q000009:adverse effects; D013623:Tail / Q000002:abnormalities
D000840:Anisoles; D003270:Contraceptive Agents; D004965:Estrogen Antagonists; D004967:Estrogens; D011759:Pyrrolidines; D013343:Styrenes